Prospera Financial Services Inc Invitae Corp Transaction History

Prospera Financial Services Inc

  • $2.97 Billion
  • Q4 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
SELL
$2.13 - $9.01 $3,591 - $15,190
-1,686 Closed
0 $0
Q1 2022

May 04, 2022
BUY
$6.28 - $15.59 $10,588 - $26,284
1,686 New
1,686 $13,000
Q4 2020

Feb 12, 2021
SELL
$39.09 - $57.4 $3,909 - $5,740
-100 Closed
0 $0
Q3 2020

Nov 04, 2020
BUY
$28.43 - $44.67 $2,843 - $4,467
100 New
100 $4,000

Others Institutions Holding NVTA

# of Institutions
56
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email